Email Updates
Go to Basic Search
Results
Total Results: 492 records
Showing results for "therapy".
-
srdr.ahrq.gov/projects/1671/studies/196207January 01, 2019 - What is the comparative effectiveness of nonpharmacologic therapy versus sham treatment, waitlist, usual … care, attention control, and no treatment after followup at the following intervals: < 1 day; 1 day … What is the comparative effectiveness of nonpharmacologic treatments (e.g. exercise, cognitive behavioral … on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of treatment … used; (4) the frequency of therapy; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196205January 01, 2020 - What is the comparative effectiveness of nonopioid pharmacologic therapy (e.g. acetaminophen, NSAIDs, … , muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments … , such as those in a different medication class; or 2) nonpharmacologic therapy for outcomes related … medical comorbidities; (3) the type of nonopioid medication; (4) dose of medication; (5) duration of treatment … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or
-
srdr.ahrq.gov/projects/1671/studies/196130January 01, 2019 - Reset Cancel Study Preview Study Title and Description Intravenous metoclopramide in the treatment … , muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments … medical comorbidities; (3) the type of nonopioid medication; (4) dose of medication; (5) duration of treatment … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … Information Comments ( 0 ) | Post/View Title Data Title Intravenous metoclopramide in the treatment
-
srdr.ahrq.gov/projects/1671/studies/196134January 01, 2019 - Study Preview Study Title and Description Buccally absorbed vs intravenous prochlorperazine for treatment … , muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments … medical comorbidities; (3) the type of nonopioid medication; (4) dose of medication; (5) duration of treatment … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … Post/View Title Data Title Buccally absorbed vs intravenous prochlorperazine for treatment
-
srdr.ahrq.gov/projects/1708January 03, 2021 - Study Creation Preview Pages Other Your Feedback: Submit Reset Cancel Project: Treatments … A Systematic Review Public Report Complete Project Summary Title and Description Title Treatments … and quantity of pills used; (5) opioid use history; (6) substance use history; (7) use of concomitant therapies … What is the comparative effectiveness of nonpharmacologic therapy versus sham treatment, waitlist, usual … Kuijper B., Tans JT., Beelen A., Nollet F., de Visser M. 2009 Efficacy of therapeutic ultrasound in
-
srdr.ahrq.gov/projects/1671/studies/196160January 01, 2019 - Submit Reset Cancel Study Preview Study Title and Description Intravenous Fluid for the Treatment … , muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments … medical comorbidities; (3) the type of nonopioid medication; (4) dose of medication; (5) duration of treatment … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … Information Comments ( 0 ) | Post/View Title Data Title Intravenous Fluid for the Treatment
-
srdr.ahrq.gov/projects/1671/studies/196146January 01, 2019 - and Description Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment … , muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments … medical comorbidities; (3) the type of nonopioid medication; (4) dose of medication; (5) duration of treatment … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … Data Title Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment
-
srdr.ahrq.gov/projects/1671/studies/196170January 01, 2019 - Description Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment … , muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments … medical comorbidities; (3) the type of nonopioid medication; (4) dose of medication; (5) duration of treatment … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment
-
srdr.ahrq.gov/projects/1671/studies/196098January 01, 2020 - Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment … , muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments … medical comorbidities; (3) the type of nonopioid medication; (4) dose of medication; (5) duration of treatment … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment
-
srdr.ahrq.gov/projects/1671/studies/196129January 01, 2019 - Submit Reset Cancel Study Preview Study Title and Description Ubrogepant for the Treatment … , muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments … medical comorbidities; (3) the type of nonopioid medication; (4) dose of medication; (5) duration of treatment … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … Publication Information Comments ( 0 ) | Post/View Title Data Title Ubrogepant for the Treatment
-
srdr.ahrq.gov/projects/1671/studies/196111January 01, 2019 - randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment … , muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments … medical comorbidities; (3) the type of nonopioid medication; (4) dose of medication; (5) duration of treatment … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment
-
srdr.ahrq.gov/projects/1671/studies/196119January 01, 2019 - Description Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment … , muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments … medical comorbidities; (3) the type of nonopioid medication; (4) dose of medication; (5) duration of treatment … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … Title Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment
-
srdr.ahrq.gov/projects/1671/studies/196182January 01, 2019 - What is the comparative effectiveness of nonopioid pharmacologic therapy (e.g. acetaminophen, NSAIDs, … , muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments … , such as those in a different medication class; or 2) nonpharmacologic therapy for outcomes related … medical comorbidities; (3) the type of nonopioid medication; (4) dose of medication; (5) duration of treatment … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or
-
srdr.ahrq.gov/projects/1671/studies/196168January 01, 2019 - What is the comparative effectiveness of nonopioid pharmacologic therapy (e.g. acetaminophen, NSAIDs, … , muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments … , such as those in a different medication class; or 2) nonpharmacologic therapy for outcomes related … medical comorbidities; (3) the type of nonopioid medication; (4) dose of medication; (5) duration of treatment … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or
-
srdr.ahrq.gov/projects/1671/studies/196089January 01, 1995 - What are the harms of opioid therapy versus nonopioid pharmacologic therapy, or nonpharmacologic therapy … What are the effects of prescribing opioid therapy versus not prescribing opioid therapy for acute treatment … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is
-
srdr.ahrq.gov/projects/1671/studies/196093January 01, 1995 - What are the harms of opioid therapy versus nonopioid pharmacologic therapy, or nonpharmacologic therapy … What are the effects of prescribing opioid therapy versus not prescribing opioid therapy for acute treatment … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is
-
srdr.ahrq.gov/projects/1671/studies/196083January 01, 1993 - What are the harms of opioid therapy versus nonopioid pharmacologic therapy, or nonpharmacologic therapy … What are the effects of prescribing opioid therapy versus not prescribing opioid therapy for acute treatment … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is
-
srdr.ahrq.gov/projects/1671/studies/196088January 01, 2008 - What are the harms of opioid therapy versus nonopioid pharmacologic therapy, or nonpharmacologic therapy … What are the effects of prescribing opioid therapy versus not prescribing opioid therapy for acute treatment … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is
-
srdr.ahrq.gov/projects/1671/studies/196090What are the harms of opioid therapy versus nonopioid pharmacologic therapy, or nonpharmacologic therapy … What are the effects of prescribing opioid therapy versus not prescribing opioid therapy for acute treatment … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is
-
srdr.ahrq.gov/projects/1671/studies/196091What are the harms of opioid therapy versus nonopioid pharmacologic therapy, or nonpharmacologic therapy … What are the effects of prescribing opioid therapy versus not prescribing opioid therapy for acute treatment … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is … For patients with episodic migraine being considered for opioid therapy for acute treatment, what is
SHARE:
Search the AHRQ Archive
Information and reports more than 5 years old may be found in the AHRQ Archive site.
Search Within A Specific AHRQ Site
You selected to view results for the following site:
